凝血抑制剂的新生物学概念。 - Suppr

Suppr

超能文献

New biological concepts on coagulation inhibitors.

作者信息

Sala N, Fontcuberta J, Rutllant M L

机构信息

Dept. Genètica molecular, Hospital Duran i Reynals, Barcelona, Spain.

出版信息

Intensive Care Med. 1993;19 Suppl 1:S3-7. doi: 10.1007/BF01738943.

DOI:10.1007/BF01738943

PMID:8227737

Abstract

摘要

相似文献

New biological concepts on coagulation inhibitors.凝血抑制剂的新生物学概念。

Intensive Care Med. 1993;19 Suppl 1:S3-7. doi: 10.1007/BF01738943.

[Molecular anomalies of coagulation inhibitors].

Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):265-6.

Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.含去氧孕烯口服避孕药长期使用后的止血情况和脂质代谢

Contraception. 1994 Aug;50(2):153-65. doi: 10.1016/0010-7824(94)90051-5.

Comparison of antithrombin III, protein C and protein S levels in capillary and venous blood of newborn infants.新生儿毛细血管血与静脉血中抗凝血酶III、蛋白C和蛋白S水平的比较。

Acta Paediatr. 1992 Mar;81(3):204-6. doi: 10.1111/j.1651-2227.1992.tb12204.x.

Hemodialysis with defibrotide: effects on coagulation parameters.使用去纤苷进行血液透析：对凝血参数的影响。

Int J Artif Organs. 1992 Oct;15(10):590-4.

Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.持续非卧床腹膜透析和血液透析患者的蛋白C、蛋白S和抗凝血酶III水平

Nephron. 1990;56(3):271-6. doi: 10.1159/000186153.

[Levels of antithrombin III and proteins C in the newborn infant].[新生儿抗凝血酶III和蛋白C水平]

Sangre (Barc). 1989 Apr;34(2):91-5.

[Resistance to activated protein C. A common genetic risk factor in venous thrombosis].[对活化蛋白C的抵抗：静脉血栓形成的常见遗传危险因素]

Lakartidningen. 1995 Sep 27;92(39):3587-90.

[The genetics of thrombosis].[血栓形成的遗传学]

Haematologica. 1991 Jun;76 Suppl 3:249-60.

Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.心脏手术期间新生儿的纤维蛋白溶解、抗凝血酶III和蛋白C

J Thorac Cardiovasc Surg. 1996 Sep;112(3):665-71. doi: 10.1016/S0022-5223(96)70050-8.

本文引用的文献

Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin.抗凝血酶III抑制α-凝血酶的两步反应机制的证明以及受肝素影响步骤的鉴定。

J Biol Chem. 1982 Dec 25;257(24):14891-5.

Structure and variation of human alpha 1-antitrypsin.人类α1-抗胰蛋白酶的结构与变异

Nature. 1982 Jul 22;298(5872):329-34. doi: 10.1038/298329a0.

Antithrombin III deficiency and thromboembolism.抗凝血酶III缺乏与血栓栓塞

Clin Haematol. 1981 Jun;10(2):369-90.

Blood coagulation.血液凝固

Annu Rev Biochem. 1980;49:765-811. doi: 10.1146/annurev.bi.49.070180.004001.

Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.肝素辅因子II。人血浆中一种依赖肝素的凝血酶抑制剂的纯化及特性

J Biol Chem. 1982 Mar 10;257(5):2162-9.

Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.凝血酶催化蛋白C活化的膜结合辅因子的分离。

J Biol Chem. 1982 Jan 25;257(2):859-64.

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.肝素的构效关系：一种对抗凝血酶III具有高亲和力并引发高抗Xa因子活性的合成五糖。

Biochem Biophys Res Commun. 1983 Oct 31;116(2):492-9. doi: 10.1016/0006-291x(83)90550-8.

Natural anticoagulant mechanisms.天然抗凝机制。

J Clin Invest. 1984 Jul;74(1):1-6. doi: 10.1172/JCI111389.

Assignment of the human antithrombin III structural gene to chromosome 1q23-25.人类抗凝血酶III结构基因定位于1号染色体q23 - 25区。

Cytogenet Cell Genet. 1985;39(1):67-9. doi: 10.1159/000132105.

Hereditary heparin cofactor II deficiency and the risk of development of thrombosis.遗传性肝素辅因子II缺乏症与血栓形成风险

Thromb Haemost. 1987 Apr 7;57(2):196-200.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验